Let’s cut through the steamy summer haze with a refreshing breeze of industry insights from Drug Channels—perfect for pondering while you float in your favorite pool: 340B Discounts Still Not Reaching Needy Patients Why do patients switch from biosimilars back to Humira? Copay accumulator programs strike again! The Grim Outlook for Retail Pharmacies Plus, a shout-out to three talented journalists. P.S. Want more real-time insights? Join my more than 64,000 LinkedIn followers for daily lin...
